HoLEP Procedure | Q&A with Naren Nimmagadda, M.D.
Naren Nimmagadda, assistant professor of urology, explains the procedure, which uses a light beam called a holmium laser to remove the interior tissue of the prostate and relieve bladder obstruction.
At the Forefront of Stress Urinary Incontinence Care
Stress urinary incontinence negatively impacts on a person’s quality of life and can be difficult to manage. Andrew Cohen, M.D., details innovation in the treatment of stress urinary incontinence for men.
Bladder Cancer in Women | Q&A with A Urologic Oncologist
Urologic oncologist Armine Smith, explains our approach to treating bladder cancer as well as the importance of continued research around bladder cancer in women.
JHGBCI Virtual Grand Rounds | Upper Tract Urothelial Cancer: It's a Team Effort
During the Johns Hopkins Greenberg Bladder Cancer Institute Grand Rounds in October 2021, Dr. Jean Hoffman-Censits and Dr. Nirmish Singla discuss how doctors get together, go over cases, and share their fields of expertise in bladder and upper tract cancers.
JHGBCI Virtual Grand Rounds | It's All Related: Kidney Health for Bladder Cancer Patients
Urologist Nirmish Singla, MD, MSc, discusses kidney health for bladder cancer patients, and how "It's All Related" during the Johns Hopkins Greenberg Bladder Cancer Institute Grand Rounds in February 2022.
Urologist Bladder Cancer Q&A | Max Kates, M.D.
Max Kates, M.D., answers common questions about bladder cancer, including who is at risk, signs and symptoms, as well as the latest treatment options at the Johns Hopkins Greenberg Bladder Cancer Institute.
Our Unique Approach to Female Urologic Reconstruction | Dr. Marisa Clifton
Female Reconstructive Urologist Marisa Clifton explains the types of conditions she treats and why specialized care for certain female urologic and pelvic health conditions is important.
Urologic oncologist Nirmish Singla, M.D., M.S.C.S., discusses our unique approach to treating patients with kidney cancer, including our latest research and clinical trials.
Urology Speaks: Ecology Meets Cancer Biology: Defining the Keystone Cancer Cell Species to Develop a Cure
Dr. Amend presents background information on the Keystone Cancer Cell, and reviews our current efforts to design treatment strategies that target the unique vulnerabilities of these cells, a theory called evolutionary double bind.
Dr. Brian Matlaga discusses kidney stone care at The Brady Urological Institute, including our personalized diagnosis and treatment options and when to refer a patient to urologic care.
Johns Hopkins specialists work together to treat and manage patients with upper tract urothelial cancer.
Active Surveillance for Kidney Cancer
Although the incidence of kidney cancer has increased dramatically over the last few decades, research led by Johns Hopkins urologists is showing many of these patients can be followed safely without the need for immediate surgery.
Johns Hopkins Urological Innovations
At the Brady Urological Institute expertise, history, research and people have led us to being pioneers in Urological advances. Exploring new diagnostics, treatments, and protocols we are reshaping the futures for men and women who previously ...
Deceased Kidney Transplant Donors with Acute Kidney Injury
Organ procurement teams are leery of accepting kidneys from deceased donors with acute kidney injury (AKI) fearing they will harm the recipients. However, a national study chaired by a Johns Hopkins kidney specialist suggests these fears may be unfounded.
Vesicoureteral Reflux (VUR) | FAQ
Dr. Heather Di Carlo, Director of Pediatric Urology Research, answers frequently asked questions about vesicoureteral reflux (VUR) including symptoms, treatment options and recovery.
#TomorrowsDiscoveries: Detecting Prostate Cancer Early – Alan Partin, M.D., Ph.D.
Alan Partin, M.D., Ph.D., and his research group develop and test blood, urine and tissue cells to detect prostate cancer early.
#TomorrowsDiscoveries: A Missile for Cancer | Dr. Theodore DeWeese
#TomorrowsDiscoveries: Dr. DeWeese and his team are testing a way to target a protein found on the surface of cancer cells, but not non-cancer cells. Their goal is to destroy cancer while protecting normal tissue.
#TomorrowsDiscoveries: Treating Prostate Cancer – Urologic Oncologist Kenneth Pienta
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.
Fusion Biopsy for Prostate Cancer
Dr. H. Ballentine Carter, professor of urology and oncology, explains the difference between a standard biopsy procedure and a fusion biopsy procedure for prostate cancer.
Dr. Armine Smith, assistant professor of urology, explains what sets Johns Hopkins bladder cancer program apart from other institutions and discusses what treatment options are offered.
Dr. Mohamad E. Allaf, Director of Minimally Invasive and Robotic Urologic Surgery, explains why physicians should refer patients to John Hopkins for prostatectomy procedures and what innovative treatments and therapies are available.
Featured Articles View All »